semaglutide off the shortage list As of February 21, 2025, FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A GLP-1 Drugs: FDA Removes Semaglutide

P values are two-sided and not adjusted for multiplicity

The Large Comorbidity Multiple studies have shown that many of the deaths attributed to the virus were because it caused a deterioration in other, underlying health conditions patients hadrather than being the sole cause of death among those worst affected

Zepbound contains tirzepatide, which is also the active ingredient in Mounjaro

In our program, which currently supports over 600 active medical weight loss patients, we regularly adjust treatment plans based on how each person responds

Platform structure: Trimi Health is a technology platform - it does not prescribe, dispense, or manufacture medication